Biomarker ID | 1871 |
PMID | 30373654 |
Year | 2018 |
Biomarker | Promoter methylation of: miR-193b+ miR-34b/c |
Biomarker Basis | Methylation Based |
Biomolecule | Methylation |
Source | Tissue |
Subjects | Humans |
Regulation | Methylated in Gleason Grade 2-5 |
Odds Ratio/Hazard Ratio/Relative Risk | Multivariate: 3.843 (95% CI: 1.268-11.649) |
Effect on Pathways | NA |
Experiment | Prostate Cancer Specific Survival Vs No Survival |
Type of Biomarker | Prognostic |
Cohort | 15 normal prostate tissues along with 74 Prostate cancer samples were selected for analysis. 13 patients died due to PCa |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.017 |
Method Used | KAPA SYBR FAST qPCR Kit |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | NA |